Rutgers Health News
Rutgers was the second-largest Phase 3 clinical research trial site for Johnson & Johnson’s COVID-19 vaccine, which applied for emergency use authorization today from the U.S. Food and Drug Administration.
The liver transplant program at Rutgers-affiliated University Hospital in Newark was ranked first in the nation, along with Harvard-affiliated Beth Israel Deaconess Medical Center in Boston, for its one-year patient survival rate, according to data from the Scienti
Rutgers is leading a clinical trial assessing the combination of nitazoxanide, ribavirin and hydroxychloroquine to treat people 21 or older who are infected with SARS-CoV-2 and are asymptomatic or mildly symptomatic.
The New Jersey Alliance for Clinical and Translational Science (NJ ACTS) at Rutgers University received a $5 million National Institutes of Health grant to launch outreach campaigns and expand access to COVID-19 testing for underserved and vulnerable
As more New Jersey school districts face COVID-19 outbreaks and some are forced to stop in-person classes, many health care experts worry about what to expect as we head into the flu season.
Pregnant women with severe or critical COVID-19 and their unborn infants face increased health risks before and after delivery, a Rutgers study finds.
Precision medicine is a rapidly growing approach to health care that focuses on finding treatments and interventions that work for people based on their genetic makeup, rather than their symptoms.
Children who take oral steroids to treat asthma or autoimmune diseases have an increased risk of diabetes, high blood pressure, and blood clots, according to Rutgers researchers.
Rutgers New Jersey Medical School will be a clinical test site for a study assessing the long term risk of chronic kidney disease in patients who recover from COVID-19.
Children born to mothers who had diabetes during pregnancy may age faster biologically and be at an increased risk for obesity and high blood pressure, according to Rutgers researchers.
New Jersey Medical School (NJMS) has been selected by Moderna as one of over 90 sites across the United States to recruit adults to volunteer for the COVID-19 vaccine trial (known as the COVE Study) that will test the safety and effectiveness of the vaccine in approximately 30,000 participants na
A Rutgers-led team may have found the key to treating inflammatory diseases like asthma, allergies, chronic fibrosis and chronic obstructive pulmonary disease (COPD).
Students preparing to return to school — in-person, remotely or both — are facing stresses unique to the type of learning they will engage in this fall.
The abnormal onset of puberty could have long term health effects including infertility in adulthood, according to Sally Radovick, Henry Rutgers Term Chair of pediatrics and senior associate dean for clinical and translational research at Rutgers Robert Wood Johnson Medical School, who has been s
As the coronavirus pandemic continues to spread rapidly across many parts of the United States – breaking records for new cases every day – questions loom about what the future will look like. Martin Blaser, director of Rutgers’ Center for Advanced Biotechnology and Medicine and professor of Med
Recent studies indicate HIV infection heightens the risk of dental cavities – but a Rutgers researcher has found evidence that the risk of cavities comes not from HIV itself but from a weakened immune system, which could be caused by other diseases.
Students at elementary and secondary schools that offer healthier food offerings and more opportunities for physical activities have a healthier body mass index, according to Rutgers researchers.
Asthma does not appear to increase the risk for a person contracting COVID-19 or influence its severity, according to a team of Rutgers researchers.
The COVID-19 pandemic is affecting the sexual and reproductive health of adolescents and young adults because of social distancing as well as limited access to contraceptive and abortion care, according to a sexual and reproductive health researcher at the Rutge
An inexpensive and readily available saline solution can be used to safely store and transport coronavirus samples and help resolve a nationwide shortage of the solution needed to complete COVID-19 testing, according to Rutgers researchers.
Rutgers’ RUCDR Infinite Biologics received an amended emergency use authorization from the FDA late Thursday for the first SARS-CoV-2 coronavirus test that will allow people to collect their own saliva at home and send to a lab for results.
If you’re not supposed to touch your face, should contact lens wearers shift to glasses during the COVID-19 pandemic?
The Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Rutgers’ RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus, t